DISEASE PROGRESSION

Clinical trials for DISEASE PROGRESSION explained in plain language.

Never miss a new study

Get alerted when new DISEASE PROGRESSION trials appear

Sign up with your email to follow new studies for DISEASE PROGRESSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Not yet finished but already full! 1

New hope for liver cancer patients with limited options after immunotherapy fails

Disease control Not yet recruiting

This study tests the drug regorafenib in about 20 adults with advanced liver cancer and moderate liver impairment (Child-Pugh B) whose cancer worsened after first-line immunotherapy. Participants take regorafenib pills daily for 3 weeks, then 1 week off, until the cancer progress…

Matched conditions: DISEASE PROGRESSION

Phase: PHASE2 • Sponsor: Ju Hyun Shim • Aim: Disease control

Last updated May 17, 2026 02:35 UTC

DISEASE PROGRESSION

Get alerted when new DISEASE PROGRESSION trials appear

New hope for liver cancer patients with limited options after immunotherapy fails